Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0HS3M
|
|||
Former ID |
DNC013569
|
|||
Drug Name |
1-(1-(pyrazin-2-yl)ethylidene)thiosemicarbazide
|
|||
Synonyms |
CHEMBL401556; AC1NT9J5; 142564-78-1; BDBM50376205; ZINC26974934; AKOS014545779; 1-(2-Pyrazinyl)ethanone thiosemicarbazone
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C7H9N5S
|
|||
Canonical SMILES |
CC(=NNC(=S)N)C1=NC=CN=C1
|
|||
InChI |
1S/C7H9N5S/c1-5(11-12-7(8)13)6-4-9-2-3-10-6/h2-4H,1H3,(H3,8,12,13)/b11-5-
|
|||
InChIKey |
LNRWBLGPWCJQEM-WZUFQYTHSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Tyrosinase (TYR) | Target Info | Inhibitor | [1] |
BioCyc | (S)-reticuline biosynthesis | |||
Eumelanin biosynthesis | ||||
L-dopachrome biosynthesis | ||||
KEGG Pathway | Tyrosine metabolism | |||
Riboflavin metabolism | ||||
Metabolic pathways | ||||
Melanogenesis | ||||
Pathwhiz Pathway | Riboflavin Metabolism | |||
Tyrosine Metabolism | ||||
WikiPathways | Dopamine metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | 1-(1-Arylethylidene)thiosemicarbazide derivatives: a new class of tyrosinase inhibitors. Bioorg Med Chem. 2008 Feb 1;16(3):1096-102. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.